Publicaciones (38) Publicaciones de HARKAITZ BENGOETXEA ODRIOZOLA

2023

  1. Effects of curcumin nanodelivery on schizophrenia and glioblastoma

    International Review of Neurobiology (Academic Press Inc.), pp. 163-203

  2. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment

    International Review of Neurobiology (Academic Press Inc.), pp. 103-143

  3. Enriched environment as a nonpharmacological neuroprotective strategy

    Experimental Biology and Medicine

  4. The role of ketamine in major depressive disorders: Effects on parvalbumin-positive interneurons in hippocampus

    Experimental Biology and Medicine

2021

  1. Murine femur micro-computed tomography and biomechanical datasets for an ovariectomy-induced osteoporosis model

    Scientific Data

  2. The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats

    British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532

2020

  1. 6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata

    British Journal of Pharmacology, Vol. 177, Núm. 17, pp. 3957-3974

  2. Enriched Environment Reverts Somatostatin Interneuron Loss in MK-801 Model of Schizophrenia

    Molecular Neurobiology, Vol. 57, Núm. 1, pp. 125-134

2019

  1. Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model

    European Neuropsychopharmacology, Vol. 29, Núm. 5, pp. 590-600

  2. High-altitude cognitive impairment is prevented by enriched environment including exercise via VEGF signaling

    Frontiers in Cellular Neuroscience, Vol. 12

  3. Therapeutic potential of cannabinoids as neuroprotective agents for damaged cells conducing to movement disorders

    International Review of Neurobiology (Academic Press Inc.), pp. 229-257

2018

  1. Correction to: Deleterious Effects of VEGFR2 and RET Inhibition in a Preclinical Model of Parkinson’s Disease (Molecular Neurobiology, (2018), 55, 1, (201-212), 10.1007/s12035-017-0733-x)

    Molecular Neurobiology

  2. Deleterious effects of VEGFR2 and RET inhibition in a preclinical model of Parkinson’s disease

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 201-212

  3. Environmental enrichment reverses tyrosine kinase inhibitor-mediated impairment through BDNF-TrkB pathway

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 43-59

  4. Erratum to: Short-Term Exposure to Enriched Environment in Adult Rats Restores MK-801-Induced Cognitive Deficits and GABAergic Interneuron Immunoreactivity Loss (Molecular Neurobiology, (2018), 55, 1, (26-41), 10.1007/s12035-017-0715-z)

    Molecular Neurobiology

  5. Ikasketaren eta oroimenaren oinarri estruktural eta molekularrak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 34, pp. 171-184

  6. Short-term exposure to enriched environment in adult rats restores MK-801-induced cognitive deficits and gabaergic interneuron immunoreactivity loss

    Molecular Neurobiology, Vol. 55, Núm. 1, pp. 26-41

  7. The Role of Interneurons in Cognitive Impairment in Schizophrenia

    Psychiatry and Neuroscience Update: From Translational Research to a Humanistic Approach: Volume III (Springer International Publishing), pp. 201-212

2017

  1. Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors

    Molecular Neurobiology, Vol. 54, Núm. 10, pp. 7722-7735

  2. Nanoformulation: A Useful Therapeutic Strategy for Improving Neuroprotection and the Neurorestorative Potential in Experimental Models of Parkinson's Disease

    International Review of Neurobiology (Academic Press Inc.), pp. 99-122